Brazil Brazil’s pharma market saw steady growth between 2005 and 2018. Revenues have more than tripled over those 13 years, ending 2018 with over USD 18 billion in revenues. Made with Visme Presentation Maker Brazil is gradually climbing the global pharma market rankings and is projected to leap ahead…
UK A new report from the UK BioIndustry Association (BIA) asserts that the UK biotech industry is booming, despite Brexit uncertainties. Financing raised by UK biotechs in 2019 was down on the record year of 2018, but up on 2016 and 2017. Made with Visme Infographic Maker A longer term perspective…
Facts A snapshot of the latest data on the French pharmaceutical industry from industry association LEEM, including market revenues, R&D investments, employment and consumption. Made with Visme Presentation Maker
Sweden Sweden’s top pharma export destinations. China is the largest single recipient of Swedish-made pharmaceuticals, followed by Germany and the USA. Made with Visme Infographic Maker The countries from which Sweden imports the most pharmaceuticals. Germany is top, followed by neighbouring Denmark, then the USA. Made with Visme Infographic Maker…
Puerto Rico Puerto Rico is far in the lead as the US state or territory that produces the most pharmaceutical products for export. The island’s export output of USD 13.2 billion in 2018 is almost double that of second-placed Indiana at USD 7 billion. Made with Visme Infographic Maker Pharmaceuticals are…
Turkey Imports and exports in Turkish pharma between 2010 and 2017. Pharmaceutical exports grew to a total of USD 898 million in 2017. These charts show both the volume and value of imported and locally-produced drugs in the Turkish pharma market between 2010 and 2017. TL 13.33 billion (USD 2.57…
UK There is much debate surrounding the potential impact on the UK’s life sciences industry of the country’s decision to leave the European Union. Here, IQVIA analysis posits ‘upside’ and ‘downside’ Brexit scenarios on pharmaceutical market sales and growth in the UK in comparison to a theoretical ‘No Brexit’ scenario. Different…
Turkey Hakan Yurdakul, Head of Economy Monitoring and Coordination at the Presidency Office of the Republic of Turkey, elaborates on the strategic importance of the pharmaceutical and healthcare industries for the Turkish economy, while providing insights into the government’s vision for the sector as well as Turkey’s collaborative, outward-looking, and holistic…
Turkey Murat Üçer, reputed macroeconomist, former advisor to the Ministry of Economy, Global Source Partners’ consultant in Turkey, co-founder of Turkey Data Monitor, and senior lecturer at Koç University, dissects the dynamics driving the Turkish economy as well as the main risks that lie ahead. With a GDP growth of 7.4…
Malta Malta has the second largest pharma trade balance per capita in the EU, the tenth in total, and was the continent’s fastest growing pharma exporter between 2001 and 2016. Malta acts a flight hub for southern Europe, with 35,000 international departures and arrivals per annum. Doing business in Malta is…
Malta Dr. Christian Cardona, Minister for the Economy, Investment and Small Businesses shares his strategic view on the evolution of Malta, a country boasting no natural resources and limited connectivity, that today proudly stands as the fastest growing economy within the European Union. Cardona details that a strong competitive edge, excellent…
Poland The value of Poland’s pharmaceutical exports shot from USD 501 million in 2005 to USD 3.475 billion in 2015, a total growth of an astounding 590% and a compound annual growth rate of 21%. Most exports go to Europe (80%) but Asian markets are becoming increasingly important to Poland and…
See our Cookie Privacy Policy Here